Cheng Shuang, Li Yuan, Zhang Ziwei, et al. Mechanism of Dingchuan Decoction in the Treatment of Cough Variant Asthma Based on Network Pharmacology and Molecular Docking Technology[J]. 2022,28(1):5-10.
Cheng Shuang, Li Yuan, Zhang Ziwei, et al. Mechanism of Dingchuan Decoction in the Treatment of Cough Variant Asthma Based on Network Pharmacology and Molecular Docking Technology[J]. 2022,28(1):5-10. DOI: 10.13407/j.cnki.jpp.1672-108X.2022.01.002.
Objective: To probe into the mechanism of Dingchuan decoction in the treatment of vough variant asthma (CVA) based on network pharmacology and molecular docking technology. Methods: Literature research and Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) were used to obtain the active components of Dingchuan decoction. And the targets of active components were predicted by TCMSP. Uniprot (universal protein resource) database was used to search the corresponding genes of targets. GeneCards and OMIM (online Mendelian inheritance in man) database were used to obtain the disease targets of CVA. Intersection target of drug target and disease target were obtained to make the Venn diagram. Cytoscape 3.7.2 software was used to make the network of “traditional Chinese medicine-active components-targets” and perform the network topology analysis. The protein interaction network was constructed by using String database and the core targets were screened. GO biological process analysis and KEGG pathway enrichment analysis were performed based on DAVID (the database for annotation
visualization and intergrated diacovery). AutoDock Vina and Pymol were used to dock the molecules of the active components with the key targets. Results: A total of 218 active components were found in Dingchuan decoction
and 452 potential targets
689 CVA-related targets and 131 intersection targets were obtained. The main core targets were serine/threonine protein kinase 1 (AKT1)
interleukin-6 (IL-6) and tumor necrosis factor (TNF)
and the common targets were mainly enriched in PI3K-Akt signaling pathway
TNF signaling pathway and Toll-like receptor signaling pathway. The results of molecular docking showed that the key components have a good binding activity with the key targets. Conclusion: Dingchuan decoction has the characteristics of multi-components
multi-targets and multi-pathways in the treatment of CVA
which lays a foundation for further study of the mechanism of Dingchuan decoction in the treatment of CVA.